AU2011224089B2 - Systems and methods for attaching a prosthesis within a body lumen or hollow organ - Google Patents

Systems and methods for attaching a prosthesis within a body lumen or hollow organ

Info

Publication number
AU2011224089B2
AU2011224089B2 AU2011224089A AU2011224089A AU2011224089B2 AU 2011224089 B2 AU2011224089 B2 AU 2011224089B2 AU 2011224089 A AU2011224089 A AU 2011224089A AU 2011224089 A AU2011224089 A AU 2011224089A AU 2011224089 B2 AU2011224089 B2 AU 2011224089B2
Authority
AU
Australia
Prior art keywords
fastener
carrier
motor
phase
driven
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2011224089A
Other versions
AU2011224089A1 (en
Inventor
Lee Bolduc
Philip R. Houle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aptus Endosystems Inc
Original Assignee
Aptus Endosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10/786,465 priority Critical
Priority to AU2005216164A priority patent/AU2005216164A1/en
Application filed by Aptus Endosystems Inc filed Critical Aptus Endosystems Inc
Priority to AU2011224089A priority patent/AU2011224089B2/en
Publication of AU2011224089A1 publication Critical patent/AU2011224089A1/en
Application granted granted Critical
Publication of AU2011224089B2 publication Critical patent/AU2011224089B2/en
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links

Abstract

Systems and methods introduce and deploy prosthesis into a blood vessel or hollow body organ by intra-vascular access. The prosthesis is secured in place by fasteners which 5 are implanted by an applier that is also deployed by intra vascular access. The applier is configured to permit controlled, selective release of the fastener in a step that is independent of the step of implantation. 2828979_1 (GHMatters) P61617.AU.1 16/09/11 26-- 30 -10 46- Fig I Fi.-2

Description

- 2 SYSTEMS AND METHODS FOR ATTACHING A PROSTHESIS WITHIN A BODY LUMEN OR HOLLOW ORGAN Related Applications 5 This application claims the benefit of United States Patent Application Serial No. 10/693,255, filed October 24, 2003, and entitled "Multi-Lumen Prosthesis Systems and Methods." This application also claims the benefit of United States Patent Application Serial No. 10/307,226, filed November 29, 2002, and 10 entitled "Intraluminal Prosthesis Attachment Systems and Methods." Field of the Invention The invention relates generally to prostheses, and in particular, the attachment of prostheses used in the repair of 15 diseased and/or damaged sections of a hollow body organ and/or a blood vessel. Background of the Invention The weakening of a vessel wall from damage or disease can lead to vessel dilatation and the formation of an aneurysm. 20 Left untreated, an aneurysm can grow in size and may eventually rupture. For example, aneurysms of the aorta primarily occur in abdominal region, usually in the infrarenal area between the renal arteries and the aortic bifurcation. Aneurysms can also 25 occur in the thoracic region between the aortic arch and renal arteries. The rupture of an aortic aneurysm results in massive hemorrhaging and has a high rate of mortality. Open surgical replacement of a diseased or damaged section of vessel can eliminate the risk of vessel rupture. In 30 this procedure, the diseased or damaged section of vessel is removed and a prosthetic graft, made either in a straight of bifurcated configuration, is installed and then permanently attached and sealed to the ends of the native vessel by suture. The prosthetic grafts for these procedures are usually 35 unsupported woven tubes and are typically made from polyester, ePTFE or other suitable materials. The grafts are longitudinally 2828979_2 (GHMatters) P61617.AU.1 21/03/14 -3 unsupported so they can accommodate changes in the morphology of the aneurysm and native vessel. However, these procedures require a large surgical incision and have a high rate of morbidity and mortality. In addition, many patients are 5 unsuitable for this type of major surgery due to other co morbidities. Endovascular aneurysm repair has been introduced to overcome the problems associated with open surgical repair. The aneurysm is bridged with a vascular prosthesis, which is placed 10 intraluminally. Typically these prosthetic grafts for aortic aneurysms are delivered collapsed on a catheter through the femoral artery. These grafts are usually designed with a fabric material attached to a metallic scaffolding (stent) structure, which expands or is expanded to contact the internal diameter of 15 the vessel. Unlike open surgical aneurysm repair, intraluminally deployed grafts are not sutured to the native vessel, but rely on either barbs extending from the stent, which penetrate into the native vessel during deployment, or the radial expansion force of the stent itself is utilized to hold the graft in 20 position. These graft attachment means do not provide the same level of attachment when compared to suture and can damage the native vessel upon deployment. Summary of the Invention Disclosed herein are apparatus, tools, systems, and 25 methods for repairing diseased and/or damaged sections of a hollow body organ and/or a blood vessel. The apparatus, tools, systems, and methods find use, e.g., in the introduction and deployment of a prosthesis into a blood vessel or hollow body organ, which desirably is achieved by intra-vascular access. The 30 prosthesis is secured in place by fasteners, which are implanted by the apparatus, tools, systems, and methods that embody one or more features of the invention, which are also desirably deployed by intra-vascular access. Disclosed herein is an applier configured to permit 35 controlled, selective release of the fastener in a step that is independent of the step of implantation. According to one 2828979_2 (GHMatters) P61617.AU.1 21/03/14 -4 embodiment, the applier includes a driven member that is carried on a tool body. The tool body can include, e.g., a tube, such as a catheter, to permit intra-vascular deployment of the driven member. The driven member is operable to apply an implantation 5 force to the fastener. A drive actuator operates the driven member. The applier also includes a fastener-engaging mechanism on the driven member. The mechanism is operable in a first condition to couple the fastener to the driven member to transfer the implantation force from the driven member to the 10 fastener. Implantation of the fastener can thereby be achieved. The mechanism is also operable in a second condition to release the fastener from the driven member. The mechanism may include a second actuator, which places the mechanism in the second condition, to release the fastener. The second actuator is 15 operable independent of the drive actuator. There can thus be a definite, stepwise separation between implanting the fastener in tissue using the implantation tool and releasing the fastener from the implantation tool after implantation is satisfactorily achieved. 20 Disclosed herein is a tool that can be used to apply an implantation force to a fastener, which is sized and configured for implantation in tissue in response to an implantation force applied according to prescribed conditions. The tool is coupled to a controller, which interrupts 25 implantation before it is completed, and interjects a "go"/"no go" decision-making step before proceeding further. The tool includes a driven member carried on a tool body. The tool body can comprise, e.g., a tube, such as a catheter. The driven member is operable to apply the implantation force. A mechanism 30 on the driven member couples the fastener to the driven member to transfer the implantation force from the driven member to the fastener. The controller may be coupled to the driven member. The controller executes differing operational phases during the implantation process. During an initial phase the driven member 35 is operated to apply the implantation force under conditions that do not achieve the prescribed conditions, so that only 2828979_2 (GHMatters) P61617.AU.1 21/03/14 -5 partial implantation of the fastener occurs. A lull phase commences at the end of the initial phase. The lull phase interrupts operation of the driven member. There is a final phase, which operates the driven member under conditions that 5 supplement the conditions of the initial phase to achieve the prescribed conditions, and thus achieve complete implantation. However, the controller requires, after the initial phase, a prescribed command to advance from the lull phase to the final phase. The lull phase requires a decision be made before 10 implantation of the fastener is finalized. If implantation during the initial phase is deemed not to be satisfactory, implantation can be aborted, and the fastener (now only partially implanted) can be withdrawn. The decision can comprise a conscious decision by the operator and/or a decision based, at 15 least in part, upon physuical or operational conditions sensed during the initial phase. Also described herein is a tool for applying an implantation force to a fastener that is sized and configured for implantation in tissue in response to an implantation force. 20 The tool comprises a driven member carried on a tool body that is operable to apply the implantation force. An element may be included that tethers the fastener to the tool body. The tethering element safeguards against inadvertent loss of the fastener prior to implantation. The tethering element includes a 25 frangible portion, so that, once the fastener is satisfactorily implanted, the tethering element can be parted from the fastener and the tool body removed. The present invention provides a motor-driven tool for applying an implantation force to a helical fastener sized 30 and configured for penetration in tissue comprising: a tool body, a drive motor carried in the tool body, a driven member coupled to the drive motor, carried by the tool body and operable to apply the implantation force 35 during operation of the drive motor, a carrier on the driven member configured to couple 2828979_2 (GHMatters) P61617.AU.1 21/03/14 -6 the fastener to the driven member to transfer the implantation force from the driven member to the fastener, the carrier comprising a distal portion wherein the distal portion remains within the tool body during implantation of the fastener, and 5 a motor control unit carried in the tool body, coupled to the drive motor, and conditioned to operate the drive motor in phases including: an initial phase operating the carrier to transfer the implantation force to the fastener under conditions that 10 result in only partial implantation of the fastener, with a distal portion of the fastener penetrating tissue such that the distal portion is implanted into the tissue, while a proximal portion of the fastener is retained within the tool body and remains coupled to the carrier, 15 a lull phase commencing automatically at the end of the initial phase interrupting operation of the carrier, and a final phase operating the carrier to release the fastener therefrom and implant the fastener in tissue, wherein after automatically entering the lull phase, 20 the motor control unit requires a final phase command to advance from the lull phase to the final phase. The present invention also provides a method for implanting a helical fastener in tissue comprising: providing a motor-driven tool as defined in any one 25 of claim 1, coupling a helical fastener to the carrier, accessing a tissue region, operating the motor control unit in the initial phase to partially implant the fastener in the tissue region, 30 deciding during the lull phase to commence the final phase, and entering the final phase command to advance the motor control unit from the lull phase to the final phase, thereby completing the implantation of the fastener in the tissue 35 region. The present invention further provides a motor-driven 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 7 tool for applying an implantation force to a helical fastener sized and configured for penetration in tissue comprising: a tool body comprising a tubular member comprising internal threads, 5 a driven member carried in the tool body; a driven member coupled to the drive motor, disposed within the tubular member of the tool body and operable to apply the implantation force during operation of the drive motor, a carrier disposed on the driven member and within 10 the tubular member of the tool body, the carrier configured to couple the fastener to the driven member to transfer the implantation force from the driven member to the fastener, the carrier comprising a distal portion having a configuration that corresponds to a configuration of a proximal end of the fastener 15 wherein the distal portion remains within the tool body during implantation of the fastener, and a motor control unit carried in the tool body, coupled to the drive motor, and conditioned to operate the drive motor in phases including: 20 an initial phase operating the carrier to transfer a partial implantation force to the fastener so that a distal portion of the fastener penetrates tissue and is implanted into the tissue, and a proximal portion of the fastener is retained within the internal threads of the tool body, wherein the 25 proximal end of the fastener engages with the distal portion of the carrier to couple the fastener to the carrier throughout the initial phase, a lull phase commencing at the end of the initial phase interrupting operation of the carrier, and 30 a final phase operating the carrier to release the fastener therefrom and implant the fastener in tissue, wherein after automatically entering the lull phase, the motor control unit requires a final phase command to advance from the lull phase to the final phase. 35 The invention also provides various systems and methods for using the above-described devices to implant tissue 2828979_2 (GHMatters) P61617.AU.1 21/03/14 -8 in a vessel or hollow body organ. Other features and advantages of the invention shall be apparent based upon the accompanying description, drawings, and claims. 5 Brief Description of the Drawings The invention will be understood from the following detailed description of preferred embodiments, taken in conjunction with the accompanying drawings, wherein: Fig. 1 is a perspective view of a prosthesis having a 10 fastening region that accommodates the introduction of one or more fasteners. Fig. 2 is a perspective view of the prosthesis shown in Fig. 1, showing the attachment of fasteners in the fastening region. 15 Fig. 3 is a perspective view of the prosthesis shown in Fig. 1 positioned within an abdominal aortic aneurysm. Fig. 4 is a perspective view of the prosthesis shown in Fig. 3 as it is being deployed by an intra-vascular catheter. Fig. 5 is a perspective view of the prosthesis shown 20 in Fig. 3 after it been deployed and as fasteners are being implanted by an intra-vascular fastener applier. Fig 6. is a side view, partly broken away and in section, of an intra-vascular fastener applier that can be used to implant fasteners in the prosthesis shown in Figs. 1 and 2, 25 in the manner shown in Fig. 5. Fig. 7 is a perspective view of a type of helical fastener that can be implanted using the intra-vascular fastener applier shown in Fig. 6. Fig. 8A(1) is an enlarged view of a carrier for 30 implanting a fastener of the type shown in Fig. 7, the carrier being located at the distal end of an intra-vascular fastener applier of the type shown in Fig. 8A(2), the carrier being shown in a condition to receive a fastener prior to implantation. Fig. 8A(2) is a side view, partly broken away and in 35 section, of a fastener applier that includes, at its distal end, a carrier as shown in Fig. 8A(1), the carrier being shown after 2828979_2 (GHMatters) P61617.AU.1 21/03/14 -9 receipt of a fastener and as the carrier is being rotated to implant the fastener in a prosthesis/tissue wall. Fig. 8B(1) is an enlarged view of the carrier shown in Fig. 8A(l), the carrier being shown in a condition to release 5 a fastener after implantation. Fig. 8B(2) is a side view, partly broken away and in section, of the fastener applier that includes, at its distal end, the carrier shown in Fig. 8B(1), the carrier being shown releasing a fastener following its implantation in a 10 prosthesis/tissue wall. Fig. 8C is a side view, partly broken away and in section, of the fastener applier shown in Fig. 8A(2), the carrier being shown withdrawing or retrieveing a fastener from a prosthesis/tissue wall. 15 Fig. 9A(1) is an enlarged view of another embodiment of a carrier for implanting a fastener of the type shown in Fig. 7, the carrier being located at the distal end of an intra vascular fastener applier of the type shown in Fig. 9A(2), the carrier being shown in a condition to receive a fastener prior 20 to implantation. Fig. 9A(2) is a side view, partly broken away and in section, of a fastener applier that includes, at its distal end, a carrier as shown in Fig. 9A(1), the carrier being shown after receipt of a fastener and as the carrier is being rotated to 25 implant the fastener in a prosthesis/tissue wall. Fig. 9B(1) is an enlarged view of the carrier shown in Fig. 9A(l), the carrier being shown in a condition to release a fastener after implantation. Fig. 9B(2) is a side view, partly broken away and in 30 section, of the fastener applier that includes, at its distal end, the carrier shown in Fig. 9B(1), the carrier being shown releasing a fastener following its implantation in a prosthesis/tissue wall. Fig. 10A(1) is an enlarged view of a carrier for 35 implanting a fastener of the type shown in Fig. 7, the carrier being located at the distal end of an intra-vascular fastener 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 10 applier of the type shown in Fig. 1OA(2), the carrier being shown in a condition to receive a fastener prior to implantation. Fig. 1OA(2) is a side view, partly broken away and in 5 section, of a fastener applier that includes, at its distal end, a carrier as shown in Fig. 10A(1), the carrier being shown after receipt of a fastener and as the carrier is being rotated to implant the fastener in a prosthesis/tissue wall. Fig. 10B(1) is an enlarged view of the carrier shown 10 in Fig. 10A(1), the carrier being shown in a condition to release a fastener after implantation. Fig. 10B(2) is a side view, partly broken away and in section, of the fastener applier that includes, at its distal end, the carrier shown in Fig. 1OB(1), the carrier being shown 15 releasing a fastener following its implantation in a prosthesis/tissue wall. Fig. 11 is an enlarged view of a carrier for implanting a fastener of the type shown in Fig. 7, the carrier being located at the distal end of an intra-vascular fastener 20 applier of the type shown in Figs. 1OA(2) and 1OB(2), the carrier being shown in a condition to receive a fastener prior to implantation. Figs. 12A and 12B are perspective views of a fastener assembly comprising a helical fastener and a cap, Fig. 12A 25 showing an exploded view of the assembly and Fig. 12B showing an assembled view of the assembly. Figs. 13A and 13B are side views showing in interior of a carrier for implanting a fastener assembly of the type shown in Fig. 12B, the carrier being located at the distal end 30 of an intra-vascular fastener applier of the type shown in Fig. 15A, the carrier in Fig. 13A being shown in a condition to receive the fastener assembly prior to implantation, the carrier in Fig. 13B being shown in a condition to release the fastener assembly after implantation. 35 Figs. 14A and 14B are side views showing the mounting of the fastener assembly shown in Fig. 12B to the carrier shown 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 11 in Fig. 13A. Fig. 15A is a side view, partly broken away and in section, of a fastener applier that includes, at its distal end, a carrier as shown in Fig. 13A, the carrier being shown after 5 receipt of a fastener assembly as shown in Fig. 14B and as the carrier is being rotated to implant the fastener assembly in a prosthesis/tissue wall. Fig. 15B is a side view, partly broken away and in section, of a fastener applier shown in Fig. 15A, the carrier 10 being shown releasing the fastener assembly after its implantation in a prosthesis/tissue wall. Fig. 15C is a side view, partly broken away and in section, of a fastener applier shown in Fig. 15A, the carrier being shown withdrawing or retrieving the fastener assembly from 15 a prosthesis/tissue wall. Fig. 16A(l) is an enlarged view of a carrier for implanting a fastener of the type shown in Fig. 7, the carrier being located at the distal end of an intra-vascular fastener applier of the type shown in Fig. 16A(2), the carrier being 20 shown holding a fastener prior to implantation. Fig. 16A(2) is a side view, partly broken away and in section, of a fastener applier that includes, at its distal end, a carrier as shown in Fig. 16A(l), the carrier being rotated to implant the fastener in a prosthesis/tissue wall. 25 Fig. 16B is a side view, partly broken away and in section, of the fastener applier shown in Fig. 16A(2), the carrier being shown at the end of a first operating phase, during which the fastener has been partially implanted in a prosthesis/tissue wall and in which the fastener remains secured 30 to the carrier. Fig. 16C is a side view, partly broken away and in ection, of the fastener applier shown in Fig. 16A(2) , the barrier being shown following the first operating phase and at the end of a second operating phase, during which the fastener 35 las been fully implanted and released from the carrier into a prosthesis/tissue wall. 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 12 Fig. 16D is a side view, partly broken away and in section, of the fastener applier shown in Fig. 16A(2), the carrier being shown following the first operating phase and during another operating phase, during which the fastener is 5 being withdrawn or retrieved from a prosthesis/tissue wall while still secured to the carrier. Figs. 17A and 17B are side views of a fastener applier of the type shown in any of the preceding Figures, the fastener applier including an element releasably tethering a 10 fastener to the fastener applier, Fig. 17A showing the tethering element holding on to the fastener following its implantation in a prosthesis/tissue wall, and Fig. 17B showing the tethering element after having been parted from the fastener. Figs. 18A and 18B show an embodiment of a tethering 15 element of the type shown in Figs. 17A and 17B, the tethering element being secure to a frangible portion of the fastener, Fig. 18A showing the tethering element holding on to the fastener following its implantation in a prosthesis/tissue wall, and Fig. 18B showing the tethering element after having been 20 parted from the fastener. Fig. 19A shows an embodiment of a tethering element of the type shown in Figs. 17A and 17B, the tethering element being secured to a frangible joint that is broken by rotating the tethering element relative to the fastener. 25 Fig. 19B shows an embodiment of a tethering element of the type shown in Figs. 17A and 17B, the tethering element being secured to a frangible joint that is broken by pulling the tethering element from the fastener. Figs. 20A and 20B show an embodiment of a tethering 30 element of the type shown in Figs. 17A and 17B, the tethering element being secured to a screw joint (Fig. 20A) that is parted by rotating the tethering element relative to the fastener (Fig. 20B). Figs. 21A and 21B show an embodiment of a tethering 35 Element of the type shown in Figs. 17A and 17B, the tethering lement being secured to a ball joint (Fig. 21A) that is parted 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 13 by pulling the tethering element away from the fastener (Fig. 21B) Figs. 22A and 22B show an embodiment of a tethering element of the type shown in Figs. 17A and 17B, the tethering 5 element being secured to a slip joint (Fig. 22A) that is parted by pulling the tethering element away from the fastener (Fig. 22B) Figs. 23A and 23B show an embodiment of a tethering element of the type shown in Figs. 17A and 17B, the tethering 10 element being secured to a knotted joint (Fig. 23A) that is parted by pulling the tethering element away from the fastener (Fig. 23B) . Figs. 24A and 24B show an embodiment of a tethering element of the type shown in Figs. 17A and 17B, the tethering 15 element being secured to a frangible tube joint (Fig. 24A) that is parted by pulling a rip cord (Fig. 24B). Figs. 25A and 25B show an embodiment of a tethering element of the type shown in Figs. 17A and 17B, the tethering element being secured by an interlocking joint (Fig. 25A) that 20 is released by pulling away a slidable sleeve (Fig. 25B). Detailed Description of the Invention I. PROSTHESIS A. Structure Fig. 1 shows a prosthesis 10. The prosthesis 10 serves to 25 repair or reinforce a region of a vessel wall or hollow body organ which has been weakened by disease or damage. In the illustrated embodiment (see Fig. 1), the prosthesis 10 comprises a tubular trunk 12. The trunk 12 is sized and configured to fit within a targeted region of a hollow body 30 organ and/or a blood vessel. The targeted region is selected on the basis of certain anatomic characteristics. These characteristics include a weakened conditioned caused, e.g., by disease or damage. The trunk 12 forms a generally cylindrical structure with 35 pn open interior lumen 18. In the illustrated embodiment, the trunk 12 includes a prosthetic material 14 supported by a 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 14 scaffold 16. The prosthetic material 14 is selected on the basis of its biocompatibility, durability, and flexible mechanical properties. The material 14 can comprise, e.g., woven polyester or ePTFE. 5 The scaffold 16 is desirable sized and configured to permit non-invasive deployment of the prosthesis 10 by an intra vascular catheter. With this criteria in mind, the scaffold 16 is sized and configured to assume a compressed or collapsed, low profile condition, to permit its intra-vascular introduction 10 into the hollow body organ and/or blood vessel by a catheter, as will be described in greater detail later. Also with this criteria in mind, the scaffold 16 is sized and configured for expansion in situ from its collapsed condition into an expanded condition in contact with tissue in 15 the targeted region, as will also be described in greater detail later. In this respect, the scaffold 16 can comprise, e.g., a malleable plastic or metal material that expands in the presence of an applied force. In this arrangement, the deployment 20 catheter can include, e.g., an expandable body, such as a balloon, to apply the expansion force to the scaffold 16 in situ. Alternatively, the scaffold 16 can comprise a self expanding plastic or metal material that can be compressed in 25 the presence of a force, but self-expands upon removal of the compressive force. In this arrangement, the deployment catheter can include, e.g., a sleeve that can be manipulated to enclosed the scaffold 16 in a collapsed condition, thereby applying the compressive force, and to release the scaffold 16 when desired 30 to allow the scaffold 16 to self-expand in situ. For self-expansion, the scaffold 16 can include individual self -expanding, zigzag type main stent rings 22. The main stent rings 22 can be made, e.g., from Nitinol* wire. Still, other materials, manufacturing methods and designs can be used. 35 The main stent rings 22 need not be attached to one another throughout the prosthesis material 14, as Fig. 1 shows. 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 15 The individual main stent rings 22 allow for longitudinal compliance while maintaining radial support of the open interior lumen 18. This technical feature allows the prosthesis 10 to more readily accommodate changes in morphology in the targeted 5 region. Still, it may be desirable in certain locations within the prosthesis structure to have attachments between the individual main stent rings 22 to provide enhanced stability and/or additional radial support. Each of the main stent rings 22 can be, e.g., sewn onto 10 prosthetic material 14. In the illustrated embodiment, in which the prosthetic material 14 is woven polyester, the attachment of the main stent rings 22 can be made, e.g., with polyester suture. However, it is also contemplated that other attachment 15 means could be utilized to secure the main stent rings 22 to the prosthetic material 14. These means include bonding; capturing the main stent rings 22 between two layers of prosthetic material 14; and incorporating the main stent rings 22 directly into the prosthetic material 14. 20 In certain locations it is desired to have the main stent rings 22 attached to the outer diameter of the prosthetic material 14. Still, it is also contemplated that the main stent rings 22 could be attached to the inner diameter of the prosthetic material 22. 25 At least one end of the trunk 12 desirably also includes one or more end stent rings 24. The principal purpose of an end stent ring 24 is to provide a seal between the trunk 12 and adjoining tissue. This sealing function is particularly desirable when the prosthesis 10 is deployed in a blood vessel 30 or other body organ, where body fluids are intended to reside or pass through the prosthesis 10. The end sent rings 24 can also serve, with the main stent rings 22, to help maintain the position of the prosthesis 10 in the targeted region. The trunk 12 (material 14 and/or scaffold 16) can carry 35 radiopaque markers 46 to help fluoroscopically position the prosthesis 10. The markers 46 can take the form, e.g. of marker 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 16 bands, tight wound coils, or wire made from radiopaque materials such as platinum, platinum/iridium, or gold. The trunk 12 also desirably includes at least one fastening region 26 that accommodates the introduction of one or 5 more fasteners 28 to anchor the prosthesis 10 in place (see Fig. 2) . It is desirable that this region 26 of the trunk 12 be specially sized and configured for the receipt and retention of fasteners 28. For example, the size and spacing of ring stent patterns can be configured in the region 26 to specially 10 accommodate the placement of fasteners; and/or woven fibers with an "X-pattern" or a "sinusoidal pattern" can be used in the region 26 to specially accommodate placement of fasteners; and/or the prosthetic material 14 can be folded-over to form multiple layers, to reinforce the prosthesis in the region 26 15 where fasteners are placed; and/or denser weave patterns or stronger fibers can be used, selected from, e.g., Kevlar m material or Vectran" material or metallic wire woven alone or interwoven with typical polyester fibers in the region 26 were fasteners are placed. It may also be desirable to 20 fluoroscopically indicate this region 26 with auxiliary radiopaque markers 30 on the prosthetic material 14, and/or auxiliary stent rings 32 to aid in positioning the fasteners. The fasteners 28 can be variously constructed. They can, e.g., comprise helical fasteners or staples. 25 Desirably, like the prosthesis 10 itself, the fasteners 28 are introduced by an intra-vascular fastener attachment assembly. Details of various fastener attachment assemblies will be described in greater detail later. B. Use of the Prosthesis 30 The targeted region for deployment of the tissue reinforcement prosthesis 10 as just described can vary. In Fig. 3, the trunk 12 is sized and configured to extend, for purposes of illustration, in the aorta adjacent the renal arteries distally to a location proximal the natural bifurcation of the 35 iliac arteries. However, this targeted site of deployment is selected for purposes of illustrating the features of the 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 17 prosthesis 10, and it is not intended to be limiting. As shown in Fig. 3, the fastening region 26 is located in !the neck of the aorta adjacent to the renal arteries. The features of the fastening region 26, previously described, make 5 possible the secure attachment of the prosthesis 10, without migration. In this arrangement (see Fig. 3), the trunk 12 may include a supra-renal stent 44 at its proximal end, which extends beyond the prosthetic material 14. When deployed within the aorta, this 10 stent 44 would extend above the level of the renal arteries, as Fig. 3 shows. The supra-renal stent 44 orients the prosthesis 10 within the lumen and aids in maintaining the position of the prosthesis 10 in the aorta without obstructing the normal blood flow into the renal arteries. 15 During use (see Figs. 4 and 5), a first catheter 20 is navigated over a guide wire 48 through an iliac to the desired location within the aorta near the renal arteries. The catheter 20 carries the prosthesis 10 in a radially reduced configuration. At the targeted site, the catheter 20 releases 20 the prosthesis 10, which expands radially into the position shown in Fig. 5. A fastener assembly 34 is next deployed (which is shown generally in Fig. 5) to place fasteners 28 into the fastening region 26 of the trunk 12. The prosthesis 10 is thereby secured 25 in position. II. PROSTHESIS ATTACHMENT SYSTEMS AND METHODS The fastener assembly 34 can be variously constructed and configured. In an illustrated arrangement (see Fig. 6), the fastener 30 attachment assembly 34 comprises a fastener guide component 36 and a fastener applier component 38. The guide component 36 can comprise, e.g., a guide sheath that desirably has a steerable or deflectable distal tip. The guide component 36 can be initially deployed over the guidewire that is used to deliver and position 35 the prosthesis 10. The guide wire can be withdrawn after the guide component 36 is deployed and positioned, so that the 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 18 applier component 38 can be introduced. In this arrangement, the applier component 38 is desirably deployed through the guide component 36. A fastener drive mechanism 40 on the fastener applier component 38 carries at 5 least one fastener 28. The fastener drive mechanism 40 advances the fastener 28, causing it to penetrate the prosthesis 10 and underlying tissue wall. In this way, the fastener anchors the prosthesis 10 firmly in place. In the illustrated embodiment (see Fig. 6), the fastener 10 applier 38 comprises a catheter 42. The catheter 42 carries the fastener drive mechanism 40 at its distal tip. The fastener drive mechanism 40 comprises carrier 50. The carrier 50 is sized and configured to carry a selected fastener 28. The fastener drive mechanism 40 also includes a driver 52, 15 which is coupled to impart movement to the carrier 50. The driver 52 and carrier 50 can comprise an integrated unit, with the carrier 50 being formed on the distal end of the driver 52, as shown, or they can comprise separate components, e.g., with the driver comprising a clutch or the like for the carrier 50. 20 The driven movement deploys the fastener 28. The type of driven movement that is imparted depends upon the type of fastener 28 that is used. In the illustrated embodiment (see Fig. 7) the fastener 28 comprises is an open helical coil 54 with a sharpened leading 25 tip 56. This type of helical fastener is deployed into tissue by rotational movement. Consequently, rotational movement is imparted by the driver 52 to the carrier 50, which is sized and configured to carry the fastener shown in Fig. 7. The actuation of the driver 52 can, of course, be 30 accomplished in various ways, e.g., mechanical (i.e., manual or hand-powered), electrical, hydraulic, or pneumatic. In the illustrated embodiment (see Fig. 6), a drive motor 58 imparts rotation to the driver 52 through a drive cable 60. In the illustrated embodiment (Fig. 6), the drive motor 58 is 35 housed in a handle 62, which is carried at the proximal end of the catheter 42. The drive cable 60 extends from the handle 62, 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 19 through the catheter 42, and couples to the driver 52 at the distal end of the catheter 42. The drive cable 60 is desirably made of a suitable material that allows for both bending and rotation. 5 Activation of the drive motor 58 (e.g., by a physician controlled switch 64 on the handle 62) rotates, as a unit, the drive shaft 60, the driver 52, the carrier 50, and the fastener 28 in the carrier 50. The rotational movement causes the helical fastener 28 to travel into the prosthesis 10 and the tissue 10 wall. The implantation force of the fastener drive mechanism 40 is desirably resolved in some manner to provide positional stability and resist unintended movement of the carrier 50 relative to the implantation site. A resolution force is 15 desirably applied to counteract and/or oppose the implantation force of the fastener drive mechanism 40. It is desirable to resolve some or all or a substantial portion of the implantation force within the vessel lumen (or other hollow body organ) itself, and preferably as close to the implantation site as 20 possible. The tubular body of the guide component 36 and/or the shaft of the catheter 42 can be sized and configured to possess sufficient column strength to resolve some or all or at least a portion of the implantation force within the vessel lumen or 25 hollow body organ. Fig. 5 shows the guide component 36 braced against the vessel wall to apply a counterbalancing resolution force. In addition, or alternatively, the guide component 36 and/or the fastener applier component 38 can include some form of stabilization means for applying a counteracting force at or 30 near the carrier 50. Various types of stabilization means are disclosed in co-pending United States Patent Application Serial Number 10/669,881, filed September 24, 2003, and entitled "Catheter-Based Fastener Implantation Apparatus and Methods with Implantation Force Resolution." 35 The carrier 50 itself can be various constructed, as can the fastener 28 to facilitate its coupling to the carrier 50. 28289792 (GHMatters) P61617.AU.1 21/03/14 - 20 Representative embodiments will now be described. A. Carriers with Independent Fastener Release Mechanisms 1. Carriers with Fastener Support Elements Having Release Mechanisms 5 The proximal end of the fastener 28 desirably includes a fitting 66 that, in use, couples the fastener 28 to the carrier 50. In one illustrated embodiment (see Fig. 7), the fitting 66 comprises an L-shaped brace or leg 66. The L-shape leg 66 desirably bisects the entire interior diameter of the coil 54; 10 that is, the L-shaped leg 66 extends completely across the interior diameter of the coil 54, as Fig. 7 shows. In this arrangement, the carrier 50 is sized and configured to engage the fitting 66, i.e., L-shaped leg 66, to thereby impart rotation to the helical fastener 28 to achieve 15 implantation. The L-shaped leg 66 also serves as a stop to prevent the helical fastener 28 from penetrating too far into the tissue. In one illustrated embodiment, the carrier 50 (see Figs. 8A(l) and 8A(2)) includes a fastener support element 68 that 20 permits the selective release of the fastener 28. The support element 68 has at least two operating conditions. In a first condition (see Fig. 8A(1)), the support element 68 engages the L-shaped leg 66 of the fastener 28 to hold the fastener 28 on the carrier 50. In the first condition, rotation 25 of the carrier 50 imparts rotation to the fastener 28 (as shown by the rotational arrow in Fig. 8A(2), to allow implantation of the fastener 28 into the prosthesis 10/tissue wall without releasing the fastener 28 (i.e., in response to rotation in one direction, as Fig. 8A(2) shows), as well as allow the withdrawal 30 the fastener 28 from the prosthesis 10/tissue wall without releasing the fastener 28 (i.e., in response to rotation in an opposite direction, as Fig. 8C shows). In a second condition (see Figs. 8B(1) and 8(B) (2)), the support element 68 releases the fastener 28. In the second 35 condition, the fastener 28 and the carrier 50 can be separated. Release of the fastener 28 from the carrier 50 can be and 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 21 desirably is accomplished without rotation of the carrier 50. It is desirable that the support element 68 can affect separation of the fastener 28 while the carrier 50 is stationary and not rotating. 5 The support element 68 therefore differentiates the step of operating the carrier 50 to implant the fastener 28 (by rotation of the carrier 59 with the support element 68 in its first condition) from the step of releasing the fastener 28 from the carrier 50 (by placing the support element 68 in its second 10 condition, which is desirably achieved independent of rotation of the carrier 50). The support element 68 thereby also makes possible the use of the carrier 50 to withdraw the fastener 28 from tissue and to retrieve or reposition the fastener 28, if desired. operation of the support element 68 independent of 15 operation of the carrier 50 makes possible the release of the fastener 28 from the carrier 50 in a separate releasing step, which can be delayed to assure that implantation of the fastener 28 has been satisfactorily completed. The features of the support element 68 just described can 20 be achieved by the use of various structural embodiments. In the embodiment shown in Figs. 8A(l) and 8B(1), for example, the support element takes the form of hinged gripping jaws 70 on the distal end of the carrier 50. The gripping jaws 70 are moveable between a mutually closed condition (i.e., the first condition, 25 as shown in Fig. 8A(l)) and a mutually opened condition (i.e., the second condition, as shown in Fig. 8B(l)). The L-shaped leg 66 of the fastener 28 is gripped by interference fit within a receptacle 72 formed between the jaws 70 when the jaws 70 are mutually closed, as Figs. 8A(l) and 8A(2) show. The receptacle 30 72 opens and frees the L-shaped leg 66 when the gripping jaws 70 are mutually opened, as Figs. 8B(1) and 8B(2) show. In this embodiment, a physician-manipulated actuator 74 selectively pivots the hinged gripping jaws 70 from their mutually closed condition to their mutually opened condition. In 35 the illustrated embodiment (see Figs. 8A(l)and 8B(l)), the actuator 74 comprises a pull cable 76 or stylet, which is 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 22 coupled at its proximal end to a controller 78 on the handle (see Figs. 8A(2) and 8B(2)). The pull cable 76 extends through the catheter 42 and terminates at its distal end with a shaped cam element 78. The cam element 78 in the illustrated embodiment 5 is ball-shaped. It occupies the area defined between tapered, facing cam surfaces 80 formed on the interior of the gripping jaws 70. When the jaws 70 are mutually closed (Fig. 8A(l)), the cam element 78 rests in the region of greatest distance between cam surfaces 80, adjacent the distal end of the gripping jaws 10 70. In this arrangement, when the physician manipulates the controller 78 to pull the cable 76 in an aft direction (i.e., toward the handle 62) (Fig. 8B), the cam element 78 travels on the tapered cam surfaces 80 toward the region of least distance between the surfaces 80. As it moves, the cam element 78 applies 15 force against the cam surfaces 80 to pivot the jaws 70 open, i.e., moving them from the mutually closed to the mutually opened condition, as Fig. 8B(1) shows. In the illustrated embodiment, the hinged gripping jaws 70 are desirably biased toward the mutually closed condition. A 20 spring can be used for the purpose. Desirably, the gripping jaws 70 are formed by machining or molding from an elastic, spring like material (metal or plastic) . The formed material includes an integral hinge 82, which normally biases the gripping jaws 70 closed. The hinge 82 yields to the force applied by the cam 25 element 78 against the cam surfaces 80, but returns the jaws 70 to their mutually closed condition in the absence of the force. In this arrangement (see Fig. 8A(1)), a physician can snap fit the L-shaped leg 66 of a fastener 28 into the receptacle 72 between the gripping jaws 70 at time of use. The snap fit 30 provides tactile assurance that the fastener 28 has been properly engaged within the receptacle 72 of the gripping jaws 70. In an alternative embodiment (see Figs. 9A(1) and 9B(1)), the support element 68 takes the form of spring-biased struts 84 35 on the carrier 50. The struts 84 resiliently open to accommodate snap-fit passage of the L-shaped leg 66 into a retaining space 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 23 87 between the struts 84, allowing the coil 54 of the fastener 28 to nest upon the struts 84 (as Fig. 9A(2) shows) . The resilient, normally closed condition of the struts 84 comprises the first operating condition, which holds the fastener 28 on 5 the struts 84, thereby securing the fastener 28 to the carrier 50. In this condition, rotation of the carrier 50 rotates the fastener 28, to allow implantation of the fastener 28 into tissue and/or withdrawal of the fastener 28 from tissue. In this arrangement, a physician-manipulated actuator 86 10 comprising, e.g., a push cable or stylet, can be advanced forward through the catheter by operation of a controller 88 on the handle 62. The carrier 50 need not be and desirably is not rotated during this operation. The push cable 86, when advanced (see Figs. 8B(1) and 8B(2), contacts the L-shaped leg 66 and 15 urges the leg 66 out of the retaining space 87 against the resiliently closed struts 84. The struts 84 are resiliently displaced by force of the L-shaped leg 66, which are caused to assume a temporary, mutually opened condition. The fastener 28 can thereby be ejected from the carrier 50. 20 In an alternative arrangement (see Figs. 10A(1) and 1OB(2)), the support element 68 may include normally open struts 90 that define a receptacle 92 and include a detent 94 that governs passage of the L-shaped leg 66 into and out of the receptacle 92. A physician-manipulated actuator 96 comprising, 25 e.g., a push-pull cable or stylet, can be advanced fore and aft through the catheter 42 into and out of contact with the detent 94, e.g., by operation of a controller 98 on the handle 62 (see Figs. 10A(2) and 10(B) (2)) . The cable 96, when advanced into contact with detent 94 (see Fig. 10A(1) (1)) locks the detent 94 30 in a position projecting into the receptacle 92. The detent 94, when locked, blocks entry into or out of the receptacle 92. The cable 96, when withdrawn from contact with detent 94, unlocks the detent 94, and allows movement of the detent 94 out of the position blocking the receptacle 92. 35 The detent 94, when unlocked (see Figs. 10A(1) and 1OA(2)), accommodates passage of the L-shaped leg 66 into the 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 24 retainer 92 between the struts 90, while the remainder of the fastener 28 nests upon the struts 90. The fastener 28 can be loaded onto the carrier 50 in this fashion. The subsequent locking of the detent 94 (see Fig. 1OA(2)) blocks release of the 5 L-shaped leg 66, securing the fastener 28 to the carrier 50. This corresponds to the above-described first operating condition. In this condition, rotation of the carrier 50 rotates the fastener 28 (as shown by the rotational arrow in Fig. 1OA(2)), to allow implantation of the fastener 28 into the 10 prosthesis 10/tissue wall and/or withdrawal of the fastener 28 from the prosthesis 10/tissue wall. The cable 96, when advanced out of contact with detent 94, unlocks the detent 94 (see Figs. 10B(1) and 10B(2)). The carrier 50 need not be and desirable is not rotated during this 15 operation. This allows passage of the L-shaped leg 66 past the detent 94 and free of the receptacle 92, as previously described, in response to aft movement of the catheter 42 and attached carrier 50. Alternatively, as shown in Fig. 11, the detent 94 may be 20 biased by a spring 100 toward a normally projecting condition to serve the same function. 2. Carriers With Releasable Fastener Cap Assemblies In another illustrated embodiment (sees Figs. 12A and 25 12B) , the fastener 28 takes the form of a fastener cap assembly 102 that is releasably fitted onto a specially adapted carrier 104 (see Figs. 14A and 14B) at time of use. In the illustrated arrangement (see Figs. 12A and 12B) , the fastener cap assembly 102 includes a helical fastener 106 on which a proximal cap 108 30 is mounted. The cap 108 can comprise a plastic, metal, or ceramic biocompatible material. The cap 108 can be secured to the proximal end of the fastener 106, e.g., by adhesives, machining, molding, or welding. The cap 108 includes preformed side mounts 110. In this arrangement, the cap 108 serves the 35 same general function as the L-shaped leg 66 shown in Fig. 7, i.e., it is a fitting secured to the fastener that enables the 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 25 coupling of the fastener 28 to the carrier. In this arrangement (see Figs. 14A and 14B), the carrier 104 includes an attachment mechanism 112, which will be described in greater detail later. The attachment mechanism 112 5 is sized and configured to engage the mounts 110, to thereby couple the fastener assembly 102 to the carrier 104 at time of use. The attachment mechanism 112 imparts rotation to the fastener assembly 102 when the carrier 104 is rotated (see Fig. 15A) to achieve implantation of the fastener assembly 102 into 10 the prosthesis 10/tissue wall without releasing the fastener assembly 102 (i.e., in response to rotation of the carrier 104 in one direction, as Fig. 15A shows) . The attachment mechanism 112 can also withdraw the fastener assembly 102 from the prosthesis 10/tissue wall (see Fig. 15C) without releasing the 15 fastener assembly 102 (i.e., in response to rotation of the carrier 104 in an opposite direction, as Fig. 15C shows). The carrier 104 also includes a release mechanism 114, as will be described in greater detail later. The release mechanism 114 selectively releases the fastener assembly 102 from the 20 attachment mechanism 112 (see Fig. 15B) . Release of the fastener assembly 102 from the attachment mechanism 112 can be and desirably is accomplished without rotation of the carrier 104. The carrier 104 with an attachment mechanism 112 to which a fastener assembly 102 can be fitted at time of use, as well as 25 an independent, selectively operable release mechanism 114 allows a physician to operate the carrier 104 to implant the fastener assembly 102 separate from the step of releasing the fastener assembly 102 after implantation has been accomplished. The carrier 104 with a selective release for the fastener 30 assembly 102 also makes possible the withdrawal the fastener assembly 102 from tissue and the retrieval and/or reposition the fastener assembly 104, if desired, while the carrier 104 remains secured to the fastener assembly 102. In this arrangement, release of the fastener assembly 102 from the carrier 104 can be 35 accomplished once fastener assembly 102 has been satisfactorily implanted, or otherwise at a time controlled by the operator. 28289792 (GHMatters) P61617.AU.1 21/03/14 - 26 The features of the carrier 104 as just described can be achieved by the use of various structural embodiments. In the embodiment shown in Figs. 13A and 13B, the attachment mechanism 112 comprises a pair of gripper arms 116 coupled to the driver 5 52. The gripper arms 116 can be made by machining or molding from a metal or plastic material. The gripper arms 116 can be normally biased toward an inwardly deflected condition. The bias can be achieved, e.g., by imparting a spring memory to the arms 116. Alternatively, the arms 116 need not be biased inwardly, 10 but instead include outside edges that are inclined, as Fig. 13B shows. The arms include outwardly projecting tabs 126 that are sized to snap into mounts 110 on the cap 108 (as Fig. 14B shows). In this arrangement, the release mechanism 114 comprises a 15 spacer rod 118 extends between the gripper arms 116. The rod 118 carries at its distal end a cam element 120. When withdrawn from contact with the gripper arms 116 (as Fig. 13B shows), the gripper arms 116 are positioned such that the tabs 126 will snap into the mounts 110 on the cap 108, as Fig. 14A shows. The cam 20 element 120, when disposed in contact with the gripper arms 116 (as shown in Fig. 13A), spreads the gripper arms 116 apart, into an outwardly deflected condition, locking the tabs 116 into the mounts 110, as Fig. 14B shows. A spring 122 normally urges the cam element 120 toward 25 contact with the gripper arms 116 (as shown in Figs. 13A and 14B). The rod 118, when pulled aft (as Figs. 13B and 14A show) withdraws the cam element 120, and the gripper arms 116 are positioned to receive the cap 108. The rod 118 extends through the catheter 42 and is coupled to a controller 124 on the handle 30 62 (see Figs. 15A and 15B). When the gripper arms 116 are maintained by the cam element 120 in their outwardly deflected condition (see Fig. 14B), the tabs 126 lock into the mounts 110 on the fastener cap 108, securing the fastener assembly 102 to the carrier 104. 35 conversely, when the cam element 120 is withdrawn, the tabs 126 allow the fastener assembly 102 to be inserted onto or separated 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 27 from the carrier 104. In use, the physician pulls back on the control 124 to withdraw the cam element 120 against the bias of the spring 122 and snap-fits a fastener assembly 102 onto the carrier 104. The 5 physician then releases the control 124 to allow the spring 122 to return forward and lock the fastener assembly 102 onto the carrier 104. The physician then deploys the catheter 42 holding the fastener assembly 102 to the targeted site (see Fig. 15A). By rotating the carrier 104, the physician implants the fastener 10 assembly 102 into the prosthesis 10/tissue wall. When the fastener assembly 102 has been satisfactorily implanted, the physician pulls back on the control 124 and the catheter 42 (see Fig. 15B) to separate the fastener assembly 102 from the carrier 104. The physician withdraws the catheter 42 and repeats the 15 forgoing steps until the desired number of fastener assemblies 102 has been implanted. B. Carriers with Two-Phase Ejection of Fasteners The above-described embodiments provide the ability to withdraw a given fastener from a prosthesis/tissue wall prior to 20 completion of the implantation step. The above-described embodiments make this feature possible by providing a fastener applier 38 that includes a fastener release mechanism that works independent of the fastener implantation mechanism. In Figs. 16A(1)/A(2), 16B, and 16C, a fastener applier 38 25 includes a fastener carrier 128 that implements this feature without an independent release mechanism. In Figs. 16A(1)/A(2), 16B, and 16C, the fastener carrier 128 is operated in two phases. The first or initial phase advances a fastener 28 into an incomplete implantation position within a prosthesis 30 10/tissue wall (Fig. 16B), which represents a sufficient distance to gain purchase, but which is short of full implantation. That is, given that full implantation of the fastener 28 requires the application of an implantation force under prescribed conditions, i.e., for a prescribed time period 35 or for a prescribed number of rotations of the fastener-- the implantation force is applied to the fastener 28 during the 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 28 first phase under conditions that do not achieve the prescribed conditions. Thus, full implantation is not achieved. During the first phase, the fastener 28 remains coupled to the fastener carrier 128, to allow the physician to operate the fastener 5 carrier 128 to withdraw/retrieve the fastener 28, if desired (see Fig. 16D). The first phase presents a decision point to the physician. At end of the first phase, a lull phase exists, during which operation of the fastener carrier 128 is 10 interrupted. A prescribed input command is required to move out of the lull phase. During the lull phase, the physician can elect to withdraw or retrieve the fastener 28 (Fig. 16D). Alternatively, the physician can elect to continue implantation and proceed to the second phase. In the second or final phase, 15 the fastener carrier 128 advances the fastener 28 from the incomplete implantation position (Fig. 16B) to the complete implantation position (Fig. 16C), at the end of which the fastener 28 itself automatically separates from the fastener carrier 128. That is, during the second phase, implantation 20 force is applied to the fastener 28 under conditions that supplement the conditions of the first phase in order to meet the conditions prescribed for full implantation. The fastener applier 38 can implement this feature in various structural embodiments. In the illustrative embodiment 25 shown in Fig. 16A(l), the carrier 128, coupled to a driver 52, includes a slot 130, which receives the L-shaped leg 66 to couple the fastener 28 for rotation with the carrier 128. In this embodiment, the turns of the coil 54 rest in complementary internal grooves 132 that surround the carrier 128. The grooves 30 132 could be positioned along the entire length of the fastener 28 or within a portion of its length. Activation of the drive mechanism rotates, as a unit, the driver 52, the carrier 128, and the helical fastener 28 (as Fig. 16A(2) shows). This rotation causes the helical fastener 28 to travel within the 35 internal grooves 132 of the fastener applier and into the prosthesis 10 and tissue wall. Uninterrupted rotation of the 28289792 (GHMatters) P61617.AU.1 21/03/14 - 29 carrier 128 will cause the helical fastener 28 to be rotated completely off the carrier and through the prosthesis 10 and into the tissue wall (as Fig. 16C shows). In the illustrated embodiment, the drive mechanism 5 includes a motor control unit 134 (see Figs. 16A(2), 16B, and 16D). The motor control unit 134 is conditioned to operate the carrier 128 in the two distinct phases, as above described. The first phase of fastener implantation is initiated by the physician activating a rotation command, e.g., by manipulating a 10 first switch 136 on the handle 62. During the first phase of deployment (Fig. 16B), the carrier 128 is driven sufficient to rotate the helical fastener 28 to a position in which the distal portion of the fastener 28 has implanted itself into the target tissue, but in which the proximal portion of the fastener 28 is 15 still retained within the internal threads 132 of the carrier 128. At this point, the first phase ends, and the motor control unit 134 enters the lull phase, automatically interrupting rotation of the carrier 128. The motor control unit 134 can accomplish motor control in this fashion by either conventional 20 mechanical and or electronic means, e.g., through a programmable microprocessor. At this juncture, the physician has the option of reversing the insertion process and removing the fastener 28, if desired (see Fig. 16D), e.g., by reversing the switch 136 or 25 activating another switch 138 on the handle 62. At this juncture, the physician also has the option of completing the implantation process, e.g., by manipulating the switch 136 in a preprogrammed fashion (for example, by double switching). In one variation, the motor control unit 136 can receive 30 input reflecting a performance criteria measured during the first phase of deployment. The motor control unit 136 assesses the value of the performance criteria, to determine whether it falls within a predetermined acceptable range. If so, the second phase of deployment may occur automatically without a pause and 35 without a second input from the user. For example, motor current used during the first phase of fastener deployment could be 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 30 measured, and from this the fastener driving torque could be calculated. A torque within a range of acceptable values would imply that the fastener 28 had successfully entered the target tissue and fastener implantation could be completed 5 automatically. A torque that was outside the acceptable range could result in either a pause at the end of phase one, where the user could make the decision to continue or reverse the fastener deployment, or an automatic reversal of fastener deployment. 10 In an alternative embodiment, a fastener release mechanism 114 of the type shown, e.g., in Figs. 13A/B and 14A/B can be used in association with a motor control unit 134. In this arrangement, the motor control unit 134 is conditioned to operate the carrier 104 to drive the fastener assembly 102 in a 15 single phase of deployment into tissue. At this point, the release mechanism 114 can be operated in the manner previously described, to separate the fastener assembly 102 from the carrier 104. The motor control unit 134 can be conditioned by mechanical and/or electronic means to indicate and/or control 20 the number of revolutions and/or the torque applied to accomplish the installation of the fastener assembly 102 in tissue. In this embodiment, there is no need for multiple phases, because the physician ultimately controls the release of the fastener assembly 102 by manipulation of the release 25 mechanism 114. C. Carriers with Tethered Fasteners In all of the above embodiments, or as an alternative embodiment in and of itself, a fastener applier 38 can include an element 140 to releasably tether a fastener 28 to the applier 30 38 even after the fastener 28 has been separated from the applier 38 (see Fig. 17A) . The tether element 140 serves as a "life line," maintaining a connection of last resort between the applier 38 and a fastener 28. The tether element 28 allows the fastener 28 to be retrieved if, for any reason, the fastener 28 35 inadvertently breaks loose from tissue and/or the applier 38 during or after implantation. The connection between the tether 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 31 element 140 and the applier 38 requires a deliberate act of the physician to be broken, adding a confirming, final step to the implantation process (see Fig. 17B). The tether element 140 can be variously constructed. In 5 Fig. 17A, the tether element 140 comprises a thread, braid, wire, or tubing structure 142. The proximal end of the tether element structure 142 is attached to the fastener applier 38 in a manner that can be detached by application of a deliberate pulling force. The distal end of the tether element structure 10 142 is frangible and can be broken by a force less than the deliberate pulling force once desired deployment of the fastener 28 is confirmed, as Fig. 17B shows. The tether element structure 142 has sufficient length to be able to retract the fastener applier 38 enough to visualize the fastener in position (as Fig. 15 17A shows). The force to break the frangible distal end of the tether element structure 142 is less than the force required to dislodge the fastener 28 from tissue. Desirably, the frangible distal end of the tether element structure 142 detaches from the fastener 28 without leaving remnants on the fastener 28 (as Fig. 20 17B shows). The tether element structure 142 can be sized and configured in other, different ways to form a frangible connection with a fastener 28. For example (see Figs. 18A and 18B), the L-shaped leg 66 could be crimped to form an area of 25 weakness 144 (Fig. 18A), to which the tether element structure 142 applies force to free the tether element structure 142 from the fastener 28 (Fig. 18B). Alternatively, the junction between the tether element structure 142 and the fastener 28 can comprise an area of 30 weakness 146 (e.g., by welding, soldering, gluing, heating, or shearing) that is broken by the application of a prescribed force in a prescribed manner, e.g., by rotation (Fig. 19A) or pulling (Fig. 19B). Alternatively, the junction between the tether element structure 142 and the fastener 28 may comprise a 35 threaded joint 146 (see Figs. 20A and 20B); or a snap-fit ball 140 and the fastener 28 can comprise an interlocking mechanism 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 32 160, for example, a slidable outer sleeve 162 that, when advanced (Fig. 25A) , captures an appendage 164 on the fastener 28 and, when retracted (Fig. 25B), frees the appendage 164. The preferred embodiments of the invention are described 5 above in detail for the purpose of setting forth a complete disclosure and for the sake of explanation and clarity. Those skilled in the art will envision other modifications within the scope and sprit of the present disclosure. The above described embodiments of this invention are 10 merely descriptive of its principles and are not to be limited. The scope of this invention instead shall be determined from the scope of the following claims, including their equivalents. In the claims which follow and in the preceding description of the invention, except where the context requires 15 otherwise due to express language or necessary implication, the word "comprise" or variations such as "comprises" or "comprising" is used in an inclusive sense, i.e. to specify the presence of the stated features but not to preclude the presence or addition of further features in various embodiments of the 20 invention. It is to be understood that, if any prior art publication is referred to herein, such reference does not constitute an admission that the publication forms a part of the common general knowledge in the art, in Australia or any other country. 2828979_2 (GHMatters) P61617.AU.1 21/03/14

Claims (20)

1. A motor-driven tool for applying an implantation force to a helical fastener sized and configured 5 for penetration in tissue comprising: a tool body, a drive motor carried in the tool body, a driven member coupled to the drive motor, carried by the tool body and operable to apply the implantation force 10 during operation of the drive motor, a carrier on the driven member configured to couple the fastener to the driven member to transfer the implantation force from the driven member to the fastener, the carrier comprising a distal portion wherein the distal portion remains 15 within the tool body during implantation of the fastener, and a motor control unit carried in the tool body, coupled to the drive motor, and conditioned to operate the drive motor in phases including: an initial phase operating the carrier to transfer 20 the implantation force to the fastener under conditions that result in only partial implantation of the fastener, with a distal portion of the fastener penetrating tissue such that the distal portion is implanted into the tissue, while a proximal portion of the fastener is retained within the tool body and 25 remains coupled to the carrier, a lull phase commencing automatically at the end of the initial phase interrupting operation of the carrier, and a final phase operating the carrier to release the fastener therefrom and implant the fastener in tissue, 30 wherein after automatically entering the lull phase, the motor control unit requires a final phase command to advance from the lull phase to the final phase.
2. A motor-driven tool according to claim 1, wherein the final phase command is based, at least in part, upon 35 input from an operator.
3. A motor-driven tool according to claim 1 or 2, 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 34 wherein the final phase command is based, at least in part, upon input reflecting a sensed operating condition.
4. A motor-driven tool according to any preceding claim, wherein the driven member is also operable to apply a 5 removal force to withdraw the fastener from tissue, and wherein the motor control unit includes a removal phase operating the carrier to transfer the removal force to the fastener, the motor control unit requiring, after automatically entering the lull phase, a removal phase command different from the final phase 10 command to advance from the lull phase to the removal phase.
5. A motor-driven tool according to claim 4, wherein the carrier is rotated in one direction to transfer the implantation force and rotated in an opposite direction to transfer the removal force. 15
6. A motor-driven tool according to any preceding claim, further including an element tethering the fastener to the tool body, the element including a frangible portion.
7. A motor-driven tool according to any preceding claim, wherein the tool body comprises a tubular member that 20 carries the driven member and the carrier.
8. A motor-driven tool according to any preceding claim, wherein the driven member is rotated to apply the implantation force.
9. A motor-driven tool according to any preceding 25 claim, wherein the tool body comprises internal threads.
10. A motor-driven tool according to claim 9, wherein the proximal portion of the fastener is retained within the internal threads of the tool body at the end of the initial phase. 30
11. A motor-driven tool according to any preceding claim, wherein the carrier comprises a distal portion having a configuration that corresponds to a configuration of a proximal end of the fastener, such that the proximal end of the fastener engages with the distal portion of the carrier to couple the 35 fastener to the carrier throughout the initial phase.
12. A motor-driven tool according to claim 11, 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 35 wherein the proximal end of the fastener comprises a leg portion that engages with the distal portion of the carrier throughout the initial phase.
13. A motor-driven tool according to any preceding 5 claim, wherein the motor-driven tool is configured to carry and deploy a single helical fastener at a time.
14. A motor-driven tool according to any preceding claim, wherein the motor-driven tool is configured to rotatably drive the fastener into the tissue. 10
15. A motor-driven tool according to any preceding claim, wherein the motor control unit comprises a programmable microprocessor configured to automatically transition the drive motor from the initial phase to the lull phase.
16. A method for implanting a helical fastener in 15 tissue comprising: providing a motor-driven tool as defined in any one of claim 1, coupling a helical fastener to the carrier, accessing a tissue region, 20 operating the motor control unit in the initial phase to partially implant the fastener in the tissue region, deciding during the lull phase to commence the final phase, and entering the final phase command to advance the motor 25 control unit from the lull phase to the final phase, thereby completing the implantation of the fastener in the tissue region.
17. A motor-driven tool for applying an implantation force to a helical fastener sized and configured 30 for penetration in tissue comprising: a tool body comprising a tubular member comprising internal threads, a driven member carried in the tool body; a driven member coupled to the drive motor, disposed 35 within the tubular member of the tool body and operable to apply the implantation force during operation of the drive motor, 2828979_2 (GHMatters) P61617.AU.1 21/03/14 - 36 a carrier disposed on the driven member and within the tubular member of the tool body, the carrier configured to couple the fastener to the driven member to transfer the implantation force from the driven member to the fastener, the 5 carrier comprising a distal portion having a configuration that corresponds to a configuration of a proximal end of the fastener wherein the distal portion remains within the tool body during implantation of the fastener, and a motor control unit carried in the tool body, 10 coupled to the drive motor, and conditioned to operate the drive motor in phases including: an initial phase operating the carrier to transfer a partial implantation force to the fastener so that a distal portion of the fastener penetrates tissue and is implanted into 15 the tissue, and a proximal portion of the fastener is retained within the internal threads of the tool body, wherein the proximal end of the fastener engages with the distal portion of the carrier to couple the fastener to the carrier throughout the initial phase, 20 a lull phase commencing at the end of the initial phase interrupting operation of the carrier, and a final phase operating the carrier to release the fastener therefrom and implant the fastener in tissue, wherein after automatically entering the lull phase, 25 the motor control unit requires a final phase command to advance from the lull phase to the final phase.
18. A motor-driven tool according to claim 17, wherein the proximal end of the fastener comprises a leg portion that engages with the distal portion of the carrier throughout 30 the initial phase.
19. A motor-driven tool substantially as herein described with reference to the accompanying drawings.
20. A method for implanting a helical fastener substantially as herein described with reference to the 35 accompanying drawings. 2828979_2 (GHMatters) P61617.AU.1 21/03/14
AU2011224089A 2004-02-25 2011-09-16 Systems and methods for attaching a prosthesis within a body lumen or hollow organ Active AU2011224089B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/786,465 2004-02-25
AU2005216164A AU2005216164A1 (en) 2004-02-25 2005-02-22 Systems and methods for attaching a prosthesis within a body lumen or hollow organ
AU2011224089A AU2011224089B2 (en) 2004-02-25 2011-09-16 Systems and methods for attaching a prosthesis within a body lumen or hollow organ

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2011224089A AU2011224089B2 (en) 2004-02-25 2011-09-16 Systems and methods for attaching a prosthesis within a body lumen or hollow organ

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2005216164A Division AU2005216164A1 (en) 2001-11-28 2005-02-22 Systems and methods for attaching a prosthesis within a body lumen or hollow organ

Publications (2)

Publication Number Publication Date
AU2011224089A1 AU2011224089A1 (en) 2011-10-06
AU2011224089B2 true AU2011224089B2 (en) 2014-04-17

Family

ID=45439632

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011224089A Active AU2011224089B2 (en) 2004-02-25 2011-09-16 Systems and methods for attaching a prosthesis within a body lumen or hollow organ

Country Status (1)

Country Link
AU (1) AU2011224089B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9023065B2 (en) 2001-11-28 2015-05-05 Aptus Endosystems, Inc. Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ
US9320589B2 (en) 2001-11-28 2016-04-26 Medtronic Vascular, Inc. Endovascular aneurysm repair system
US9320503B2 (en) 2001-11-28 2016-04-26 Medtronic Vascular, Inc. Devices, system, and methods for guiding an operative tool into an interior body region
US9808250B2 (en) 2001-11-28 2017-11-07 Medtronic Vascular, Inc. Systems and methods for attaching a prosthesis within a body lumen or hollow organ
US9848869B2 (en) 2001-11-28 2017-12-26 Medtronic Vascular, Inc. Prosthesis systems and methods
US10098770B2 (en) 2001-11-28 2018-10-16 Medtronic Vascular, Inc. Endovascular aneurysm devices, systems, and methods
US10194905B2 (en) 2001-11-28 2019-02-05 Medtronic Vascular, Inc. Devices, systems, and methods for endovascular staple and/or prosthesis delivery and implantation

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491232B2 (en) 1998-09-18 2009-02-17 Aptus Endosystems, Inc. Catheter-based fastener implantation apparatus and methods with implantation force resolution

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5320630A (en) * 1993-02-23 1994-06-14 Munir Ahmed Endoscopic ligating instrument for applying elastic bands
US5334196A (en) * 1992-10-05 1994-08-02 United States Surgical Corporation Endoscopic fastener remover

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334196A (en) * 1992-10-05 1994-08-02 United States Surgical Corporation Endoscopic fastener remover
US5320630A (en) * 1993-02-23 1994-06-14 Munir Ahmed Endoscopic ligating instrument for applying elastic bands

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9023065B2 (en) 2001-11-28 2015-05-05 Aptus Endosystems, Inc. Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ
US9320589B2 (en) 2001-11-28 2016-04-26 Medtronic Vascular, Inc. Endovascular aneurysm repair system
US9320503B2 (en) 2001-11-28 2016-04-26 Medtronic Vascular, Inc. Devices, system, and methods for guiding an operative tool into an interior body region
US9808250B2 (en) 2001-11-28 2017-11-07 Medtronic Vascular, Inc. Systems and methods for attaching a prosthesis within a body lumen or hollow organ
US9848869B2 (en) 2001-11-28 2017-12-26 Medtronic Vascular, Inc. Prosthesis systems and methods
US10098770B2 (en) 2001-11-28 2018-10-16 Medtronic Vascular, Inc. Endovascular aneurysm devices, systems, and methods
US10194905B2 (en) 2001-11-28 2019-02-05 Medtronic Vascular, Inc. Devices, systems, and methods for endovascular staple and/or prosthesis delivery and implantation

Also Published As

Publication number Publication date
AU2011224089A1 (en) 2011-10-06

Similar Documents

Publication Publication Date Title
CN1870950B (en) Systems and methods for prosthesis delivery
US8236049B2 (en) Multipiece prosthetic mitral valve and method
CA2329213C (en) Low profile stent and graft combination
EP1061985B1 (en) Delivery system for deployment and endovascular assembly of multi-stage stent graft
EP2529698B1 (en) Repositionable heart valve
US6416536B1 (en) Method for deployment of a low profile delivery system
EP1401357B1 (en) Implant having means for fixation to a body lumen
US8043305B2 (en) Method of securing a graft
CA2400072C (en) Endovascular stent graft
EP1706070B1 (en) Multiple stitches for attaching stent to graft
EP1482866B1 (en) Apparatus for deployment of an endoluminal device
US8083752B2 (en) Endovascular aneurysm repair systems and methods
US5354310A (en) Expandable temporary graft
EP2617388B1 (en) Medical devices and delivery systems for delivering medical devices
JP5111365B2 (en) Intravascular cuff
EP0809476B1 (en) Endoprosthesis stent/graft deployment system
US8764811B2 (en) Controlled tip release stent graft delivery system and method
US7955380B2 (en) Prosthesis fixation apparatus and methods
US7854758B2 (en) Exclusion of ascending/descending aorta and/or aortic arch aneurysm
US20070168013A1 (en) Vascular graft and deployment system
US20060069424A1 (en) Self-constrained segmented stents and methods for their deployment
EP1791498B1 (en) Stent graft with integral side arm
JP3784886B2 (en) Medical spring assembly equipment
US20070021822A1 (en) Fenestrated endoluminal stent system
EP2734157B1 (en) Apparatus for tricuspid valve repair using tension

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)